Company intelligence / Profile preview

Enovo Life Sciences

Brussels, Belgiumenovolifesciences.com ↗

Ownership: Private
Development stage: Other

Overview

Enovo Life Sciences is a newly launched, institutionally capitalized life sciences platform focused on acquiring and integrating businesses serving the biologics and advanced therapies end markets. Backed by Warburg Pincus, it aims to build a market-leading business through targeted acquisitions in bioprocessing and life science tools. The company does not currently have its own clinical pipeline or results but leverages the experience of its leadership team in scaling similar businesses such as Polyplus.

Modalities: BiologicAdvanced therapy
Industry: Investors

Partnerships

Warburg Pincus (financial partner/backer)

Beyond the preview

Go deeper on Enovo Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enovo Life Sciences.

Explore the full profile